Psyence Biomedical (PBM) EBITDA (2023 - 2025)
Psyence Biomedical (PBM) recorded quarterly EBITDA of -$752618.0 in Q3 2025, down 1898.59% quarter-over-quarter from $41845.0 in Q3 2024, and down 1898.59% on a YoY basis from $41845.0 in Q3 2024.
Psyence Biomedical (PBM) EBITDA (2023 - 2025) Analysis & Trends
Psyence Biomedical's EBITDA history runs 3 years deep, the most recent figure standing at -$752618.0 for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 661.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -752,618.00 |
| Sep 30, 2024 | 41,845.00 |
| Mar 31, 2023 | -3.23 Mn |